In contrast, the level of Bcl-2 was increased 1.5- and 1.5-fold when treated with 1 and 5 μM ALS for 48 h, respectively, compared to the control cells (Figure 5B and Figure S5B). Here, BCL2 is linked to amyotrophic lateral sclerosis.